image
Healthcare - Biotechnology - NASDAQ - US
$ 6.14
0.656 %
$ 520 M
Market Cap
-2.5
P/E
Price Target Average
228.99%
Revenue Forecast Estimate
4.97%
EBIT Estimate
26.25%
Net Income Estimate
--2.73%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Verve Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for VERV of $20.2 , with forecasts ranging from a low of $13 to a high of $30 .
VERV Lowest Price Target Wall Street Target
13 USD 111.73%
VERV Average Price Target Wall Street Target
20.2 USD 228.99%
VERV Highest Price Target Wall Street Target
30 USD 388.60%
REVENUE FORECAST

Revenue Forecast Chart VERV

image
EBIT FORECAST

EBIT Forecast Chart VERV

image
NET INCOME FORECAST

Net Income Chart VERV

image